Page last updated: 2024-12-05

2-(methylthio)benzothiazole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-methylthio-1,3-benzothiazole : An organic sulfide that is the methyl thioether of 1,3-benzothiazole-2-thiol. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID11989
CHEMBL ID1303065
CHEBI ID1217
SCHEMBL ID316415
MeSH IDM0052401

Synonyms (67)

Synonym
AC-19507
nsc 41046
ai3-51102
einecs 210-417-1
2748l341ky ,
nsc 5352
unii-2748l341ky
2-(methylthio)benzo[d]thiazole
2-(methylthio)benzothiazole
nsc5352
nsc-5352
benzothiazole, 2-(methylthio)-
2-(methylmercapto)benzothiazole
smr000112274
MLS000541593
nsc41046
nsc-41046
IFLAB1_004499
benzothiazolethiol, 2-methyl-
benzothiazole, mercapto-2-methyl-
usaf ek-4008
2-methyl mercaptobenzothiazole
2-methylmercaptobenzothiazole
mtbt
IDI1_010254
inchi=1/c8h7ns2/c1-10-8-9-6-4-2-3-5-7(6)11-8/h2-5h,1h
2-(methylthio)-1,3-benzothiazole
615-22-5
2-methylthiobenzothiazole
2-(methylthio)benzothiazole, 97%
2-(methylsulfanyl)-1,3-benzothiazole
CHEBI:1217 ,
2-methylthio-1,3-benzothiazole
2-methylsulfanyl-1,3-benzothiazole
AKOS002235202
2-mercaptobenzothiazole methyl ether
M0439
A833277
NCGC00246570-01
31621-01-9
benzothiazole, (methylthio)-
CHEMBL1303065
HMS2267P24
64036-43-7
FT-0608859
MS-1432
EPITOPE ID:138945
(methylthio)benzothiazole
methylcaptax
SCHEMBL316415
2-methylmercaptobenzthiazole
2-methylthio-benzothiazole
W-105142
2-(methylthio)benzothiozole
2-(methylsulfanyl)-1,3-benzothiazole #
DTXSID70274236
mfcd00005784
benzothiazole,(methylthio)-
CS-W023165
2-mesbth
SY037966
2-methylthio benzothiazole
Q15999703
AM9910
W11130
2-methylsulfanyl-benzothiazole
EN300-111974
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
aryl hydrocarbon receptor agonistAn agonist that binds to and activates aryl hydrocarbon receptors (AhRs).
xenobiotic metaboliteAny metabolite produced by metabolism of a xenobiotic compound.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
benzothiazoles
methyl sulfideAny aliphatic sulfide in which at least one of the organyl groups attached to the sulfur is a methyl group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Beta-lactamaseEscherichia coli K-12Potency0.63100.044717.8581100.0000AID485294
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (19)

Assay IDTitleYearJournalArticle
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1331616Cytotoxicity against human PC3 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay2016European journal of medicinal chemistry, Nov-10, Volume: 123Chalcogen containing heterocyclic scaffolds: New hybrids with antitumoral activity.
AID1331617Cytotoxicity against human 184B5 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay2016European journal of medicinal chemistry, Nov-10, Volume: 123Chalcogen containing heterocyclic scaffolds: New hybrids with antitumoral activity.
AID1331618Selectivity index, ratio of GI50 for human 184B5 cells to GI50 for human MCF7 cells2016European journal of medicinal chemistry, Nov-10, Volume: 123Chalcogen containing heterocyclic scaffolds: New hybrids with antitumoral activity.
AID1331615Cytotoxicity against human MCF7 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay2016European journal of medicinal chemistry, Nov-10, Volume: 123Chalcogen containing heterocyclic scaffolds: New hybrids with antitumoral activity.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (18.18)18.7374
1990's0 (0.00)18.2507
2000's2 (18.18)29.6817
2010's5 (45.45)24.3611
2020's2 (18.18)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 24.97

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index24.97 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index4.12 (4.65)
Search Engine Demand Index26.67 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (24.97)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]